Abstract:Background: Nasopharyngeal carcinoma (NPC) is one of the most common cancers in southern China. In addition to environmental factors such as Epstein-Barr virus infection and diet, genetic susceptibility has been reported to play a key role in the development of this disease. The x-ray repair cross-complementing group 1 (XRCC1) gene is important in DNA base excision repair. We hypothesized that two common single nucleotide polymorphisms of XRCC1 (codons 194 Arg --> Trp and 399 Arg --> Gln) are related to the risk of NPC and interact with tobacco smoking.Methods: We sought to determine whether these genetic variants of the XRCC1 gene were associated with the risk of NPC among the Cantonese population in a hospital-based case control study using polymerase chain reaction-restriction fragment length polymorphism analysis. We conducted this study in 462 NPC patients and 511 healthy controls.Results: After adjustment for sex and age, we found a reduced risk of developing NPC in individuals with the Trp194Trp genotype ( OR = 0.48; 95% CI, 0.27 - 0.86) and the Arg194Trp genotype ( OR = 0.79; 95% CI, 0.60 - 1.05) compared with those with the Arg194Arg genotype. Compared with those with the Arg399Arg genotype, the risk for NPC was not significantly different in individuals with the Arg399Gln genotype ( OR = 0.82; 95% CI, 0.62 - 1.08) and the Gln399Gln genotype ( OR = 1.20; 95% CI, 0.69 - 2.06). Further analyses stratified by gender and smoking status revealed a significantly reduced risk of NPC among males ( OR = 0.32; 95% CI, 0.14 - 0.70) and smokers ( OR = 0.34; 95% CI, 0.14 - 0.82) carrying the XRCC1 194Trp/Trp genotype compared with those carrying the Arg/Arg genotype. No association was observed between Arg399Gln variant genotypes and the risk of NPC combined with smoking and gender.Conclusion: Our findings suggest that the XRCC1 Trp194Trp variant genotype is associated with a reduced risk of developing NPC in Cantonese population, particularly in males and smokers. Larger studies are needed to confirm our findings and unravel the underlying mechanisms.

Lack of association between XRCC1 SNPs and acute radiation‑induced injury or prognosis in patients with nasopharyngeal carcinoma

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy.

ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma.

The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinoma.

Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.

Relationship Between Polymorphisms of XRCC1 and the Short-Term Effect of Radiotherapy of Nasopharygeal Carcinoma

Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients

A Two-Stage Genome-Wide Association Study to Identify Novel Genetic Loci Associated with Acute Radiotherapy Toxicity in Nasopharyngeal Carcinoma.

The Association of XRCC1 Gene Single Nucleotide Polymorphisms with Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma.

The impacts of genetic polymorphisms in genes of base excision repair pathway on the efficacy and acute toxicities of (chemo)radiotherapy in patients with nasopharyngeal carcinoma.

Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinoma.

Impact of Polymorphisms in Angiogenesis-Related Genes on Clinical Outcomes of Radiotherapy in Patients with Nasopharyngeal Carcinoma.

ASSOCIATION OF XRCC3 AND XPD751 SNP WITH RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN ADVANCED NSCLC PATIENTS

Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy

Polymorphisms of XRCC1 Genes and Risk of Nasopharyngeal Carcinoma in the Cantonese Population

Genetic Variations in Radiation and Chemotherapy Drug Action Pathways Predict Clinical Outcomes in Locoregionally Advanced Nasopharyngeal Carcinoma

A two-stage genome-wide association study identifies novel germline genetic variations in CACNA2D3 associated with radiotherapy response in nasopharyngeal carcinoma

Predictive Single Nucleotide Polymorphism Markers for Acute Oral Mucositis in Patients with Nasopharyngeal Carcinoma Treated with Radiotherapy

No association between XRCC1 polymorphisms and survival in non-small-cell lung cancer patients treated with platinum-based chemotherapy.

Effects of gene polymorphisms in the endoplasmic reticulum stress pathway on clinical outcomes of chemoradiotherapy in Chinese patients with nasopharyngeal carcinoma